Calcijex and Dilaudid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Calcijex (calcitriol) and Dilaudid (hydromorphone hydrochloride). Common drug interactions include pain of skin among females and angina pectoris among males.

The phase IV clinical study analyzes what interactions people have when they take Calcijex and Dilaudid. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Calcijex?

Calcijex has active ingredients of calcitriol. eHealthMe is studying from 263 Calcijex users. Check the latest studies of Calcijex.

What is Dilaudid?

Dilaudid has active ingredients of hydromorphone hydrochloride. It is often used in pain. eHealthMe is studying from 96,466 Dilaudid users. Check the latest studies of Dilaudid.



On Jul, 19, 2026

17 people who take Calcijex and Dilaudid together, and have interactions are studied.

Calcijex and Dilaudid drug interactions.

What are the common drug interactions of Calcijex and Dilaudid, by gender? *:

female:

  1. Pain of skin
  2. Skin fibrosis (fibrous tissue formation on skin)
  3. Skin hyperpigmentation (disorders affect the colour of your skin)
  4. Skin induration (an abnormally hard spot or area on the skin)
  5. Skin tightness
  6. Oedema (fluid collection in tissue)
  7. Cellulitis (infection under the skin)
  8. Deformity (disfigurement)
  9. Erythema (redness of the skin)
  10. Fatigue (feeling of tiredness)

male:

  1. Angina pectoris (chest pain due to ischemia of the heart muscle)
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
  4. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  5. Depression
  6. Suicidal ideation

What are the common drug interactions of Calcijex and Dilaudid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Abasia (inability to walk)
  2. Arthralgia (joint pain)
  3. Bone pain
  4. Calcinosis (calcium deposits in any soft tissue)
  5. Conjunctival hyperaemia (congestion of conjunctival vessels)
  6. Corneal deposits
  7. Extremity contracture (permanent shortening of a muscle or joint of arms and legs)
  8. Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
  9. Grip strength decreased
  10. Joint lock

40-49:

n/a

50-59:

  1. Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
  2. Joint range of motion decreased (disease of joint movement)
  3. Joint stiffness
  4. Mobility decreased (ability to move is reduced)
  5. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  6. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  7. Oedema peripheral (superficial swelling)
  8. Pain of skin
  9. Scar
  10. Skin exfoliation (removal of the oldest dead skin cells)

60+:

  1. Angina pectoris (chest pain due to ischemia of the heart muscle)
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
  4. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  5. Depression
  6. Suicidal ideation

What are the existing conditions these people have? *

  1. Nuclear Magnetic Resonance Imaging Brain: 13 people, 76.47%
  2. Stress And Anxiety: 12 people, 70.59%
  3. Nausea (feeling of having an urge to vomit): 12 people, 70.59%
  4. Itching: 12 people, 70.59%
  5. High Blood Cholesterol: 12 people, 70.59%
  6. Herpes Zoster: 12 people, 70.59%
  7. Gastritis Erosive (a break in the surface layer of the membrane lining the stomach with infection): 12 people, 70.59%
  8. Device Related Infection: 12 people, 70.59%
  9. Depression: 12 people, 70.59%
  10. Nuclear Magnetic Resonance Imaging Abdominal: 8 people, 47.06%

* Approximation only. Some reports may have incomplete information.

Do you take Calcijex and Dilaudid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Calcijex and Dilaudid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Calcijex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Dilaudid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Calcijex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dilaudid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on calcitriol and hydromorphone hydrochloride (the active ingredients of Calcijex and Dilaudid, respectively), and Calcijex and Dilaudid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: